Dergi makalesi Açık Erişim

Dual-Inhibition of mTOR and Bcl-2 Enhances the Anti-tumor Effect of Everolimus against Renal Cell Carcinoma In Vitro and In Vivo

Nayman, Ayse Hande; Siginc, Halime; Zemheri, Ebru; Yencilek, Faruk; Yildirim, Asif; Telci, Dilek


JSON

{
  "conceptrecid": "69816", 
  "created": "2021-03-16T03:07:14.231537+00:00", 
  "doi": "10.7150/jca.29192", 
  "files": [
    {
      "bucket": "b473c04a-ed03-4c9c-b368-6c001cebb7d3", 
      "checksum": "md5:950a0bd95d92b57c994b620f558d93b7", 
      "key": "bib-5c465d76-6695-4ee9-9268-8d5e173d8c18.txt", 
      "links": {
        "self": "https://aperta.ulakbim.gov.tr/api/files/b473c04a-ed03-4c9c-b368-6c001cebb7d3/bib-5c465d76-6695-4ee9-9268-8d5e173d8c18.txt"
      }, 
      "size": 250, 
      "type": "txt"
    }
  ], 
  "id": 69817, 
  "links": {
    "badge": "https://aperta.ulakbim.gov.tr/badge/doi/10.7150/jca.29192.svg", 
    "bucket": "https://aperta.ulakbim.gov.tr/api/files/b473c04a-ed03-4c9c-b368-6c001cebb7d3", 
    "doi": "https://doi.org/10.7150/jca.29192", 
    "html": "https://aperta.ulakbim.gov.tr/record/69817", 
    "latest": "https://aperta.ulakbim.gov.tr/api/records/69817", 
    "latest_html": "https://aperta.ulakbim.gov.tr/record/69817"
  }, 
  "metadata": {
    "access_right": "open", 
    "access_right_category": "success", 
    "communities": [
      {
        "id": "tubitak-destekli-proje-yayinlari"
      }
    ], 
    "creators": [
      {
        "affiliation": "Yeditepe Univ, Fac Engn, Dept Genet & Bioengn, Kayisdagi Cad, TR-34755 Istanbul, Turkey", 
        "name": "Nayman, Ayse Hande"
      }, 
      {
        "affiliation": "Yeditepe Univ, Fac Engn, Dept Genet & Bioengn, Kayisdagi Cad, TR-34755 Istanbul, Turkey", 
        "name": "Siginc, Halime"
      }, 
      {
        "affiliation": "Umraniye Training & Res Hosp, Dept Pathol, Istanbul, Turkey", 
        "name": "Zemheri, Ebru"
      }, 
      {
        "affiliation": "Yeditepe Univ, Fac Sch Med, Yeditepe Univ Hosp, Istanbul, Turkey", 
        "name": "Yencilek, Faruk"
      }, 
      {
        "affiliation": "Medeniyet Univ, Fac Med, Dept Urol, Istanbul, Turkey", 
        "name": "Yildirim, Asif"
      }, 
      {
        "affiliation": "Yeditepe Univ, Fac Engn, Dept Genet & Bioengn, Kayisdagi Cad, TR-34755 Istanbul, Turkey", 
        "name": "Telci, Dilek"
      }
    ], 
    "description": "Renal cell carcinoma (RCC) is the predominant type of kidney cancer. Mammalian target of rapamycin (mTOR) inhibitor everolimus is currently used as a second-line therapy for sorafenib or sunitinib-refractory metastatic RCC patients. The clinical limitation confronted during everolimus therapy is the onset of drug resistance that decreases the efficacy of the drug. Elevated level of anti-apoptotic Bcl-2 protein is proposed to be an emerging feedback loop for the acquired drug-resistance in various cancer types. In this study, the Bcl-2 inhibitor ABT-737 was used in combination with everolimus to enhance its anti-tumor effectiveness in everolimus-resistant RCC cell lines. Everolimus and ABT-737 combination synergistically led to a decrease in the proliferation of primary site A-498 and metastatic site Caki-1 RCC cell lines, which was accompanied by a reduction in protein levels of cell cycle and mTOR pathway proteins. In both RCC cell lines, everolimus-ABT-737 combination not only induced apoptosis, caspase and PARP-1 cleavage but also a decrease in Bcl-2 protein levels in parallel with a concomitant increase in Bim and Noxa levels.", 
    "doi": "10.7150/jca.29192", 
    "has_grant": false, 
    "journal": {
      "issue": "6", 
      "pages": "1466-1478", 
      "title": "JOURNAL OF CANCER", 
      "volume": "10"
    }, 
    "license": {
      "id": "cc-by"
    }, 
    "publication_date": "2019-01-01", 
    "relations": {
      "version": [
        {
          "count": 1, 
          "index": 0, 
          "is_last": true, 
          "last_child": {
            "pid_type": "recid", 
            "pid_value": "69817"
          }, 
          "parent": {
            "pid_type": "recid", 
            "pid_value": "69816"
          }
        }
      ]
    }, 
    "resource_type": {
      "subtype": "article", 
      "title": "Dergi makalesi", 
      "type": "publication"
    }, 
    "title": "Dual-Inhibition of mTOR and Bcl-2 Enhances the Anti-tumor Effect of Everolimus against Renal Cell Carcinoma In Vitro and In Vivo"
  }, 
  "owners": [
    1
  ], 
  "revision": 1, 
  "stats": {
    "downloads": 7.0, 
    "unique_downloads": 7.0, 
    "unique_views": 50.0, 
    "version_downloads": 7.0, 
    "version_unique_downloads": 7.0, 
    "version_unique_views": 50.0, 
    "version_views": 54.0, 
    "version_volume": 1750.0, 
    "views": 54.0, 
    "volume": 1750.0
  }, 
  "updated": "2021-03-16T03:07:14.280521+00:00"
}
54
7
görüntülenme
indirilme
Görüntülenme 54
İndirme 7
Veri hacmi 1.8 kB
Tekil görüntülenme 50
Tekil indirme 7

Alıntı yap